What Could Happen Next in the Russia-Ukraine Peace Process
After meeting with President Trump separately, Presidents Putin and Zelenskiy could be headed toward a pivotal face-to-face meeting to begin peace talks. But what each side is willing to give up to end the Russia-Ukraine war remains to be seen. On today’s Big Take podcast, David Gura sits down with Bloomberg’s White House correspondent Justin Sink and Europe government editor Piotr Skolimowski to discuss Russia and Ukraine’s red lines and the role the US and Europe could play in guaranteeing a ceasefire.See omnystudio.com/listener for privacy information.
19 Aug 18min
How The Hunger Crisis in Gaza Unfolded Despite Months of Warnings
At this point in the war between Israel and Hamas, it’s difficult to get more than anecdotal evidence out of Gaza. Almost every organization that once provided aid and monitored civilian welfare is no longer allowed in — or has ceased operations. Very few journalists are left there. But reports of a civilian population facing a hunger crisis are widespread. To understand the reality on the ground, host David Gura talked to Bloomberg’s Israel bureau chief Ethan Bronner, UN reporter Magdalena Del Valle and Gaza reporter Fares Alghoul to understand how a hunger crisis unfolded there despite months of warnings. Read more: How Gaza Descended Into a Hunger Crisis, Explained Israel Intends to Fully Take Over Gaza Despite Global IsolationSee omnystudio.com/listener for privacy information.
18 Aug 24min
Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier.
When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried. On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown. Read more: How Hims Became the King of Knockoff Weight-Loss Drugs Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe? The Weight-Loss Drug Boom’s Prescription Problem Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.See omnystudio.com/listener for privacy information.
15 Aug 15min
Why Trump Is Letting Nvidia Sell (Some) AI Chips to China
In an unusual deal, Nvidia and Advanced Micro Devices have agreed to pay the US government 15% of their revenue from AI chips they sell to China. The US has blocked the sale of other, more powerful chips to China on the basis of national security, but the exception underscores the Trump administration’s openness to make exceptions… if the price is right. On today’s Big Take podcast, Bloomberg economic statecraft reporter Joe Deaux joins host Sarah Holder to explain the unprecedented nature of the deal, concerns about its legality and how it fits into Trump’s approach to trade with global competitors.See omnystudio.com/listener for privacy information.
14 Aug 18min
What’s at Stake Ahead of Trump-Putin Meeting
President Donald Trump is heading to Alaska to host a face-to-face meeting with his Russian counterpart, Vladimir Putin to talk about finally, maybe, putting an end to Russia’s war with Ukraine. Notably not invited? Ukraine — or any other European leaders. Today on the show, Bloomberg editor Flavia Krause-Jackson joins host David Gura to talk about why Russia has finally agreed to talk, what’s likely to be on the table in Anchorage and how significant this summit might be.See omnystudio.com/listener for privacy information.
13 Aug 18min
How China Is Bringing Hong Kong’s IPO Market Back to Life
After a years-long slump, Hong Kong’s IPO market is roaring back to life, thanks to a growing number of Chinese companies that are raising billions of dollars in the city. On today’s Big Take Asia Podcast, host K. Oanh Ha and Bloomberg’s Dave Sebastian explore how China is transforming the financial hub into a key funding engine for mainland firms— and the risks this poses for banks on Wall Street and beyond.See omnystudio.com/listener for privacy information.
12 Aug 14min
Who’s Really Paying for Tariffs? Hint: It’s Not Foreign Companies
President Trump’s so-called reciprocal tariffs have pushed the average US tariff rate to 15%, up from just over 2% last year. But who’s actually footing the bill so far? On today’s Big Take podcast, Bloomberg Businessweek’s “Everybody’s Business” host Stacey Vanek Smith takes Sarah Holder through Tariff 101: How is that money being collected and where is it going? Read more: It’s Only a Matter of Time Until Americans Pay for Trump’s TariffsSee omnystudio.com/listener for privacy information.
11 Aug 16min
Who Will Win the Race for Greenland’s Rare Earths?
For years, President Donald Trump has voiced his ambitions to expand the US presence in Greenland. But making that happen is easier said than done. Bloomberg’s Joe Deaux traveled to the remote island this spring, alongside a former Trump administration official who’s hoping to build a rare-earths mine there — with the federal government’s investment. On today’s Big Take podcast, Joe walks host David Gura through what he saw on the ground, what Greenlanders have to say about Trump’s rhetoric and what it would really take to establish a mines-to-magnets pipeline in Greenland. Read more: Greenland’s Rare-Earth Dreams Are Luring Trump AlliesSee omnystudio.com/listener for privacy information.
8 Aug 18min
